Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas

Rubella is a viral disease with minor morbidity and few complications unless it is contracted by a pregnant woman. Rubella infection during the first trimester of pregnancy often leads to fetal death or severe congenital defects (congenital rubella syndrome, CRS). Rubella remains endemic in many cou...

Full description

Bibliographic Details
Main Authors: Alan R. Hinman, Bradley S. Hersh, Ciro A. de Quadros
Format: Article in Journal/Newspaper
Language:English
Spanish
Portuguese
Published: Pan American Health Organization 1998
Subjects:
R
Online Access:https://doaj.org/article/070c7d0c19a64ca79e3278f66647cf9a
id ftdoajarticles:oai:doaj.org/article:070c7d0c19a64ca79e3278f66647cf9a
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:070c7d0c19a64ca79e3278f66647cf9a 2023-05-15T15:18:16+02:00 Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas Alan R. Hinman Bradley S. Hersh Ciro A. de Quadros 1998-09-01T00:00:00Z https://doaj.org/article/070c7d0c19a64ca79e3278f66647cf9a EN ES PT eng spa por Pan American Health Organization http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998000900002 https://doaj.org/toc/1020-4989 https://doaj.org/toc/1680-5348 1020-4989 1680-5348 https://doaj.org/article/070c7d0c19a64ca79e3278f66647cf9a Revista Panamericana de Salud Pública, Vol 4, Iss 3 (1998) Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 1998 ftdoajarticles 2022-12-31T04:44:43Z Rubella is a viral disease with minor morbidity and few complications unless it is contracted by a pregnant woman. Rubella infection during the first trimester of pregnancy often leads to fetal death or severe congenital defects (congenital rubella syndrome, CRS). Rubella remains endemic in many countries of Latin America and the Caribbean. It has been estimated that 20000 or more infants are perhaps born with CRS each year in Latin American and Caribbean countries. While the inclusion of rubella vaccination into routine childhood immunization will decrease rubella virus circulation among young children, it will not have immediate impact on the transmission of rubella among adults or the occurrence of CRS. A one-time mass campaign targeting both males and females 5 to 39 years of age with measles-mumps-rubella or measles-rubella vaccine followed by the use of measles-mumps-rubella vaccine in routine early childhood vaccination will prevent and control both rubella and CRS promptly. In April 1988, the Ministers of Health of the English-speaking Caribbean targeted rubella for elimination by the end of the year 2000 using the vaccination strategy outlined above. The rubella elimination experience of these countries will provide useful information for the eventual elimination of rubella virus from the Americas. La rubéola es una enfermedad vírica que produce poca morbilidad y pocas complicaciones, a no ser que la contraiga una mujer embarazada. La infección con rubéola durante el primer trimestre del embarazo a menudo termina en muerte fetal o en deformidades congénitas graves (síndrome de anomalías congénitas por rubéola, o SCR). La rubéola sigue siendo endémica en muchos países de América Latina y el Caribe. Se estima que quizá 20 000 niños o más nacen cada año con SCR en países latinoamericanos y caribeños. Si bien la adición de la vacuna contra la rubéola a los programas de inmunización infantil de rutina disminuirá la circulación del virus entre los niños pequeños, no tendrá un impacto inmediato sobre la ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
Spanish
Portuguese
topic Medicine
R
Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Medicine
R
Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Alan R. Hinman
Bradley S. Hersh
Ciro A. de Quadros
Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
topic_facet Medicine
R
Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
description Rubella is a viral disease with minor morbidity and few complications unless it is contracted by a pregnant woman. Rubella infection during the first trimester of pregnancy often leads to fetal death or severe congenital defects (congenital rubella syndrome, CRS). Rubella remains endemic in many countries of Latin America and the Caribbean. It has been estimated that 20000 or more infants are perhaps born with CRS each year in Latin American and Caribbean countries. While the inclusion of rubella vaccination into routine childhood immunization will decrease rubella virus circulation among young children, it will not have immediate impact on the transmission of rubella among adults or the occurrence of CRS. A one-time mass campaign targeting both males and females 5 to 39 years of age with measles-mumps-rubella or measles-rubella vaccine followed by the use of measles-mumps-rubella vaccine in routine early childhood vaccination will prevent and control both rubella and CRS promptly. In April 1988, the Ministers of Health of the English-speaking Caribbean targeted rubella for elimination by the end of the year 2000 using the vaccination strategy outlined above. The rubella elimination experience of these countries will provide useful information for the eventual elimination of rubella virus from the Americas. La rubéola es una enfermedad vírica que produce poca morbilidad y pocas complicaciones, a no ser que la contraiga una mujer embarazada. La infección con rubéola durante el primer trimestre del embarazo a menudo termina en muerte fetal o en deformidades congénitas graves (síndrome de anomalías congénitas por rubéola, o SCR). La rubéola sigue siendo endémica en muchos países de América Latina y el Caribe. Se estima que quizá 20 000 niños o más nacen cada año con SCR en países latinoamericanos y caribeños. Si bien la adición de la vacuna contra la rubéola a los programas de inmunización infantil de rutina disminuirá la circulación del virus entre los niños pequeños, no tendrá un impacto inmediato sobre la ...
format Article in Journal/Newspaper
author Alan R. Hinman
Bradley S. Hersh
Ciro A. de Quadros
author_facet Alan R. Hinman
Bradley S. Hersh
Ciro A. de Quadros
author_sort Alan R. Hinman
title Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
title_short Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
title_full Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
title_fullStr Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
title_full_unstemmed Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
title_sort rational use of rubella vaccine for prevention of congenital rubella syndrome in the americas
publisher Pan American Health Organization
publishDate 1998
url https://doaj.org/article/070c7d0c19a64ca79e3278f66647cf9a
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Revista Panamericana de Salud Pública, Vol 4, Iss 3 (1998)
op_relation http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998000900002
https://doaj.org/toc/1020-4989
https://doaj.org/toc/1680-5348
1020-4989
1680-5348
https://doaj.org/article/070c7d0c19a64ca79e3278f66647cf9a
_version_ 1766348480551321600